Tags

Type your tag names separated by a space and hit enter

Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
Pediatrics 1985; 75(5):819-26Ped

Abstract

A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in three divided doses for ten days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the two groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in one patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the two regimens.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

4039433

Citation

Odio, C M., et al. "Comparative Treatment Trial of Augmentin Versus Cefaclor for Acute Otitis Media With Effusion." Pediatrics, vol. 75, no. 5, 1985, pp. 819-26.
Odio CM, Kusmiesz H, Shelton S, et al. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion. Pediatrics. 1985;75(5):819-26.
Odio, C. M., Kusmiesz, H., Shelton, S., & Nelson, J. D. (1985). Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion. Pediatrics, 75(5), pp. 819-26.
Odio CM, et al. Comparative Treatment Trial of Augmentin Versus Cefaclor for Acute Otitis Media With Effusion. Pediatrics. 1985;75(5):819-26. PubMed PMID: 4039433.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion. AU - Odio,C M, AU - Kusmiesz,H, AU - Shelton,S, AU - Nelson,J D, PY - 1985/5/1/pubmed PY - 1985/5/1/medline PY - 1985/5/1/entrez SP - 819 EP - 26 JF - Pediatrics JO - Pediatrics VL - 75 IS - 5 N2 - A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in three divided doses for ten days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for follow-up examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the two groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in one patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the two regimens. SN - 0031-4005 UR - https://www.unboundmedicine.com/medline/citation/4039433/Comparative_treatment_trial_of_augmentin_versus_cefaclor_for_acute_otitis_media_with_effusion_ L2 - http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=4039433 DB - PRIME DP - Unbound Medicine ER -